Cytognomix has received a Notice of Allowance from the US Patent and Trademark office for our patent application, “Centromere Detector and Method for Determining Radiation Exposure From Chromosome Abnormalities.” All claims that were applied for were allowed in the soon to be issued patent.
The application is available at this link: US Patent Application Ser. No 13/822,289
The application was originally filed November 4, 2011 as international patent application: PCT/US11/59257. This application was deemed patentable after examination, and was entered into the Patent Prosecution Highway program. Other applications remain pending in other jurisdictions.